Topics

Multiple firms collaborate to develop new DDIRC

07:11 EDT 13 Sep 2019 | EPM Magazine

Elsevier, an information analytics business, is working together with a set of evaluation partners including Boehringer Ingelheim, Eli Lilly and Company, Pierre Fabre, Sanofi, Servier, and others to develop a new DDIRC.

Original Article: Multiple firms collaborate to develop new DDIRC

NEXT ARTICLE

More From BioPortfolio on "Multiple firms collaborate to develop new DDIRC"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...